BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 14647238)

  • 1. Involvement of c-Fos in fenretinide-induced apoptosis in human ovarian carcinoma cells.
    Appierto V; Villani MG; Cavadini E; Lotan R; Vinson C; Formelli F
    Cell Death Differ; 2004 Mar; 11(3):270-9. PubMed ID: 14647238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of gene expression identifies PLAB as a mediator of the apoptotic activity of fenretinide in human ovarian cancer cells.
    Appierto V; Villani MG; Cavadini E; Gariboldi M; De Cecco L; Pierotti MA; Lambert JR; Reid J; Tiberio P; Colombo N; Formelli F
    Oncogene; 2007 Jun; 26(27):3952-62. PubMed ID: 17213814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
    Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F
    Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the fenretinide metabolite 4-oxo-fenretinide present in human plasma and formed in human ovarian carcinoma cells through induction of cytochrome P450 26A1.
    Villani MG; Appierto V; Cavadini E; Valsecchi M; Sonnino S; Curley RW; Formelli F
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6265-75. PubMed ID: 15448016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease in drug accumulation and in tumour aggressiveness marker expression in a fenretinide-induced resistant ovarian tumour cell line.
    Appierto V; Cavadini E; Pergolizzi R; Cleris L; Lotan R; Canevari S; Formelli F
    Br J Cancer; 2001 Jun; 84(11):1528-34. PubMed ID: 11384104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AF1q: a novel mediator of basal and 4-HPR-induced apoptosis in ovarian cancer cells.
    Tiberio P; Cavadini E; Callari M; Daidone MG; Appierto V
    PLoS One; 2012; 7(6):e39968. PubMed ID: 22761939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of apoptosis and stress response in ovarian carcinoma cell lines treated with ST1926, an atypical retinoid.
    Zuco V; Zanchi C; Cassinelli G; Lanzi C; Supino R; Pisano C; Zanier R; Giordano V; Garattini E; Zunino F
    Cell Death Differ; 2004 Mar; 11(3):280-9. PubMed ID: 14657960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of retinoids on cancerous phenotype and apoptosis in organotypic cultures of ovarian carcinoma.
    Guruswamy S; Lightfoot S; Gold MA; Hassan R; Berlin KD; Ivey RT; Benbrook DM
    J Natl Cancer Inst; 2001 Apr; 93(7):516-25. PubMed ID: 11287445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators.
    Batra S; Reynolds CP; Maurer BJ
    Cancer Res; 2004 Aug; 64(15):5415-24. PubMed ID: 15289350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gangliosides link the acidic sphingomyelinase-mediated induction of ceramide to 12-lipoxygenase-dependent apoptosis of neuroblastoma in response to fenretinide.
    Lovat PE; Di Sano F; Corazzari M; Fazi B; Donnorso RP; Pearson AD; Hall AG; Redfern CP; Piacentini M
    J Natl Cancer Inst; 2004 Sep; 96(17):1288-99. PubMed ID: 15339967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression.
    Aubert N; Falluel-Morel A; Vaudry D; Xifro X; Rodriguez-Alvarez J; Fisch C; de Jouffrey S; Lebigot JF; Fournier A; Vaudry H; Gonzalez BJ
    J Neurochem; 2006 Nov; 99(4):1237-50. PubMed ID: 17026529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines.
    Maurer BJ; Metelitsa LS; Seeger RC; Cabot MC; Reynolds CP
    J Natl Cancer Inst; 1999 Jul; 91(13):1138-46. PubMed ID: 10393722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-HPR modulates gene expression in ovarian cells.
    Brewer M; Kirkpatrick ND; Wharton JT; Wang J; Hatch K; Auersperg N; Utzinger U; Gershenson D; Bast R; Zou C
    Int J Cancer; 2006 Sep; 119(5):1005-13. PubMed ID: 16570282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro model of normal, immortalized ovarian surface epithelial and ovarian cancer cells for chemoprevention of ovarian cancer.
    Brewer M; Wharton JT; Wang J; McWatters A; Auersperg N; Gershenson D; Bast R; Zou C
    Gynecol Oncol; 2005 Aug; 98(2):182-92. PubMed ID: 15907982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the mechanism of induction of apoptosis in ovarian carcinoma cells by the conformationally restricted synthetic retinoids CD437 and 4-HPR.
    Holmes WF; Soprano DR; Soprano KJ
    J Cell Biochem; 2003 May; 89(2):262-78. PubMed ID: 12704790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation and inhibition of the AP-1 complex in human breast cancer cells.
    Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH
    Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BBC3 mediates fenretinide-induced cell death in neuroblastoma.
    Wei JS; Whiteford CC; Cenacchi N; Son CG; Khan J
    Oncogene; 2005 Dec; 24(54):7976-83. PubMed ID: 16091745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products.
    Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB
    Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingosine kinase mediates resistance to the synthetic retinoid N-(4-hydroxyphenyl)retinamide in human ovarian cancer cells.
    Illuzzi G; Bernacchioni C; Aureli M; Prioni S; Frera G; Donati C; Valsecchi M; Chigorno V; Bruni P; Sonnino S; Prinetti A
    J Biol Chem; 2010 Jun; 285(24):18594-602. PubMed ID: 20404323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GADD45A is a mediator of CD437 induced apoptosis in ovarian carcinoma cells.
    Jiang T; Soprano DR; Soprano KJ
    J Cell Physiol; 2007 Sep; 212(3):771-9. PubMed ID: 17474084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.